These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1980007

  • 1. Preferential loss of maternal alleles in sporadic Wilms' tumour.
    Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J, Cowell JK.
    Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
    [Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
    Wadey RB, Pal N, Buckle B, Yeomans E, Pritchard J, Cowell JK.
    Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic mosaicism in normal tissues of Wilms' tumour patients.
    Chao LY, Huff V, Tomlinson G, Riccardi VM, Strong LC, Saunders GF.
    Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N, Arbour L, Tonin P, Baruchel S, Pritchard-Jones K, Narod SA, Stratton MR.
    Oncogene; 1997 Jun 26; 14(25):3099-102. PubMed ID: 9223674
    [Abstract] [Full Text] [Related]

  • 9. Molecular and cellular biology of Wilms' tumour.
    Maitland NJ, Brown KW, Poirier V, Shaw AP, Williams J.
    Anticancer Res; 1989 Jun 26; 9(5):1417-26. PubMed ID: 2556071
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK.
    Nature; 1988 Nov 24; 336(6197):374-6. PubMed ID: 2848199
    [Abstract] [Full Text] [Related]

  • 12. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
    Overall ML, Spencer J, Bakker M, Dziadek M, Smith PJ.
    Genes Chromosomes Cancer; 1996 Sep 24; 17(1):56-9. PubMed ID: 8889507
    [Abstract] [Full Text] [Related]

  • 13. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP.
    Nat Genet; 1994 Jul 24; 7(3):433-9. PubMed ID: 7920665
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular analysis of the chromosome 11p region in renal cell carcinomas.
    Kovacs G, Kiechle-Schwarz M, Scherer G, Kung HF.
    Cell Mol Biol; 1992 Feb 24; 38(1):59-62. PubMed ID: 1348450
    [Abstract] [Full Text] [Related]

  • 16. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
    Satoh Y, Nakadate H, Nakagawachi T, Higashimoto K, Joh K, Masaki Z, Uozumi J, Kaneko Y, Mukai T, Soejima H.
    Br J Cancer; 2006 Aug 21; 95(4):541-7. PubMed ID: 16909133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG, Pritchard J, Scambler P, Cowell JK.
    Oncogene; 1998 Jul 23; 17(3):395-400. PubMed ID: 9690521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.
    Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL.
    Hum Genet; 1988 Dec 23; 81(1):41-8. PubMed ID: 2848758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.